Los Angeles, Calif. — In a groundbreaking study conducted in Los Angeles, researchers have found that any form of substance use treatment significantly contributes to the reduction of crystal meth (methamphetamine) use among gay and bisexual men. The study challenges the conventional abstinence-only approach, emphasizing the importance of harm reduction strategies in managing methamphetamine use. The findings shed light on the severe health challenges associated with prolonged methamphetamine use and the potential benefits of adopting a more flexible and achievable treatment approach.
THE DANGERS OF METHAMPHETAMINE
Regular use of methamphetamine has been linked to various physical and mental health issues, including heart disease, HIV, anxiety, paranoia, and the risk of overdose. Methamphetamine use, especially among gay and bisexual men, is associated with increased risks of HIV transmission and treatment failure. The study underscores the need for effective treatment methods to address the specific challenges faced by this population.
USAGE PATTERNS & HARM REDUCTION
The study recognizes that methamphetamine use among gay and bisexual men can manifest in different patterns, from frequent to occasional use, abstinence, and relapse. Instead of focusing solely on complete abstinence, researchers suggest that reductions in usage patterns over time can have significant benefits and are more attainable for most users.
LACK OF APPROVED MEDICATIONS
Unlike opioids, there are currently no approved medications specifically designed to assist in managing or reducing methamphetamine use. The study notes potential interventions such as antidepressants in conjunction with naltrexone but highlights the lack of widespread treatment approaches using these medications.
COGNITIVE & BEHAVIORIAL INTERVENTIONS
The research suggests the effectiveness of cognitive and behavioral interventions, including relapse prevention, coping skills therapy, social and environmental changes, and incentivizing periods of abstinence, often with financial rewards. However, the study underscores the need for more understanding of long-term methamphetamine use patterns and the impact of substance use treatment on these patterns.
THE mSTUDY COHORT & RESEARCH METHODOLOGY
Gay and bisexual men in Los Angeles, including those with HIV and those at risk, participated in the mSTUDY cohort since 2014. The study analyzed data from 285 participants reporting methamphetamine use across 2,348 study visits between 2014 and 2022. The participants, predominantly living with HIV, attended biannual visits where they reported substance use and treatment information.
KEY FINDINGS
Frequency Categories: Participants were categorized as frequent users (daily), occasional users (weekly or less), or non-users.
Treatment Impact: Men receiving substance use treatment were significantly more likely to reduce their methamphetamine use compared to those not receiving treatment.
Positive Outcomes: Individuals receiving treatment were 1.63 times more likely to move from occasional to no use and 4.25 times more likely to move from frequent to occasional use.
No Increase in Use: Current substance use treatment was not associated with an increase in methamphetamine use.
CONCLUSION
The study’s authors highlight the significance of substance use treatment, suggesting that being connected to the treatment system itself may be valuable. These findings are groundbreaking, showcasing that individuals reduce their methamphetamine use following treatment, thereby lowering health risks and improving overall well-being. The study advocates for a broader understanding of treatment outcomes beyond the conventional requirement for complete abstinence.
